Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Cardiovascular Translational Research
Erschienen in: Journal of Cardiovascular Translational Research 2/2012

01.04.2012

Cellular Electrophysiological Abnormalities in Dyssynchronous Hearts and During CRT

verfasst von: Marc Vanderheyden, Martin Penicka, Jozef Bartunek

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

To date, cardiac resynchronization therapy remains the only treatment that enhances systolic function while improving long-term outcome and survival. Dyssynchronous heart failure is characterized by profound global as well as regional cellular and molecular changes, many of which are not observed in synchronous heart failure. The beneficial effects of CRT on myofilament function, G protein-coupled receptor signaling, and adrenergic response are important components for restoring cardiac reserve and reducing arrhythmia, both major limitations in heart failure. Here, we review the molecular alterations associated with dyssynchronous heart failure and their reversibility induced by cardiac resynchronization therapy.
Literatur
1.
Dickstein, K., Vardas, P. E., Auricchio, A., et al. (2010). 2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Journal of Heart Failure, 12(11), 1143–1153.PubMedCrossRef
2.
Nelson, G. S., Berger, R. D., Fetics, B. J., et al. (2000). Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation, 102(25), 3053–3059.PubMed
3.
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine, 352(15), 1539–1549.PubMedCrossRef
4.
Abraham, W. T., Fisher, W. G., Smith, A. L., et al. (2002). Cardiac resynchronization in chronic heart failure. The New England Journal of Medicine, 346(24), 1845–1853.PubMedCrossRef
5.
Linde, C., Leclercq, C., Rex, S., et al. (2002). Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. JAC, 40(1), 111–118.
6.
Auricchio, A., Stellbrink, C., Block, M., et al. (1999). Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation, 99(23), 2993–3001.PubMed
7.
Ypenburg, C., van Bommel, R. J., Borleffs, C. J. W., et al. (2009). Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. Journal of the American College of Cardiology, 53(6), 483–490.PubMedCrossRef
8.
Vanderheyden, M., & Bartunek, J. (2009). Cardiac resynchronization therapy in dyssynchronous heart failure: zooming in on cellular and molecular mechanisms. Circulation, 119(9), 1192–1194.PubMedCrossRef
9.
van Oosterhout, M. F., Prinzen, F. W., Arts, T., et al. (1998). Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation, 98(6), 588–595.PubMed
10.
Vernooy, K., Verbeek, X. A. A. M., Peschar, M., et al. (2005). Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. European Heart Journal, 26(1), 91–98.PubMedCrossRef
11.
Vernooy, K., Cornelussen, R. N. M., Verbeek, X. A. A. M., et al. (2007). Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts. European Heart Journal, 28(17), 2148–2155.PubMedCrossRef
12.
Leclercq, C., & Kass, D. A. (2002). Retiming the failing heart: principles and current clinical status of cardiac resynchronization. JAC, 39(2), 194–201.
13.
Prinzen, F. W., Vernooy, K., DeBoeck, B. W. L., & Delhaas, T. (2010). Mechano-energetics of the asynchronous and resynchronized heart. Heart Failure Reviews, 16(3), 215–224.CrossRef
14.
Gao, Z., Barth, A. S., DiSilvestre, D., et al. (2008). Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. Physiological Genomics, 35(3), 222–230.PubMedCrossRef
15.
Spragg, D. D., Leclercq, C., Loghmani, M., et al. (2003). Regional alterations in protein expression in the dyssynchronous failing heart. Circulation, 108(8), 929–932.PubMedCrossRef
16.
Baller, D., Wolpers, H. G., Zipfel, J., Bretschneider, H. J., & Hellige, G. (1988). Comparison of the effects of right atrial, right ventricular apex and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency: a laboratory investigation. Pacing and Clinical Electrophysiology, 11(4), 394–403.PubMedCrossRef
17.
Boerth, R. C., & Covell, J. W. (1971). Mechanical performance and efficiency of the left ventricle during ventricular stimulation. American Journal of Physiology, 221(6), 1686–1691.PubMed
18.
Bahler, R. C., & Martin, P. (1985). Effects of loading conditions and inotropic state on rapid filling phase of left ventricle. American Journal of Physiology, 248(4 Pt 2), H523–H533.PubMed
19.
Leclercq, C., Gras, D., Le Helloco, A., Nicol, L., Mabo, P., & Daubert, C. (1995). Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. American Heart Journal, 129(6), 1133–1141.PubMedCrossRef
20.
Owen, C. H., Esposito, D. J., Davis, J. W., & Glower, D. D. (1998). The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing and Clinical Electrophysiology, 21(7), 1417–1429.PubMedCrossRef
21.
Auricchio, A., & Prinzen, F. W. (2008). Update on the pathophysiological basics of cardiac resynchronization therapy. Europace, 10(7), 797–800.PubMedCrossRef
22.
Mills, R. W., Cornelussen, R. N., Mulligan, L. J., et al. (2009). Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiency. Circulation. Arrhythmia and Electrophysiology, 2(5), 571–579.PubMedCrossRef
23.
Cheng, A., Helm, R. H., & Abraham, T. P. (2009). Pathophysiological mechanisms underlying ventricular dyssynchrony. Europace, 11(Suppl 5), v10–v14.PubMedCrossRef
24.
Yu, C.-M., Lin, H., Zhang, Q., & Sanderson, J. E. (2003). High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart, 89(1), 54–60.PubMedCrossRef
25.
Haghjoo, M., Bagherzadeh, A., Fazelifar, A. F., et al. (2007). Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations. Pacing and Clinical Electrophysiology, 30(5), 616–622.PubMedCrossRef
26.
Bleeker, G. B., Schalij, M. J., Molhoek, S. G., et al. (2005). Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complex. AJC, 95(1), 140–142.CrossRef
27.
Leclercq, C., Faris, O., Tunin, R., et al. (2002). Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation, 106(14), 1760–1763.PubMedCrossRef
28.
Prinzen, F. W., & Peschar, M. (2002). Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing and Clinical Electrophysiology, 25(4 Pt 1), 484–498.PubMedCrossRef
29.
Kass, D. A. (2009). Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm, 6(11), 1660–1665.PubMedCrossRef
30.
Sengupta, P. P., Tondato, F., Khandheria, B. K., Belohlavek, M., & Jahangir, A. (2008). Electromechanical activation sequence in normal heart. Heart Failure Clinics, 4(3), 303–314.PubMedCrossRef
31.
Vanderheyden, M., Vrints, C., & Bartunek, J. (2011). The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy. Heart Failure Reviews, 16(3), 227–233.PubMedCrossRef
32.
Bartunek, J., Vanderheyden, M., Knaapen, M. W. N., Tack, W., Kockx, M. M., & Goethals, M. (2002). Deoxyribonucleic acid damage/repair proteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 40(6), 1097–1103. discussion 1104–5.PubMedCrossRef
33.
Vanderheyden, M., Mullens, W., Delrue, L., et al. (2008). Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. Journal of Cardiac Failure, 14(2), 172–178.PubMedCrossRef
34.
Vanderheyden, M., Mullens, W., Delrue, L., et al. (2008). Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. Journal of the American College of Cardiology, 51(2), 129–136.PubMedCrossRef
35.
Chakir, K., Daya, S. K., Tunin, R. S., et al. (2008). Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation, 117(11), 1369–1377.PubMedCrossRef
36.
D’Ascia, C. (2005). Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. European Heart Journal, 27(2), 201–206.PubMedCrossRef
37.
Bilchick, K. C., Saha, S. K., Mikolajczyk, E., et al. (2006). Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse. Physiological Genomics, 26(2), 109–115.PubMedCrossRef
38.
Barth, A. S., Aiba, T., Halperin, V., et al. (2009). Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circulation. Cardiovascular Genetics, 2(4), 371–378.PubMedCrossRef
39.
Lowes, B. D., Gilbert, E. M., Abraham, W. T., et al. (2002). Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. The New England Journal of Medicine, 346(18), 1357–1365.PubMedCrossRef
40.
Ambardekar, A. V., & Buttrick, P. M. (2011). Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circulation. Heart Failure, 4(2), 224–233.PubMedCrossRef
41.
Mullens, W., Bartunek, J., Wilson Tang, W. H., et al. (2008). Early and late effects of cardiac resynchronization therapy on force–frequency relation and contractility regulating gene expression in heart failure patients. Heart Rhythm, 5(1), 52–59.PubMedCrossRef
42.
Spragg, D. D., Akar, F. G., Helm, R. H., Tunin, R. S., Tomaselli, G. F., & Kass, D. A. (2005). Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovascular Research, 67(1), 77–86.PubMedCrossRef
43.
Spragg, D. D., & Kass, D. A. (2006). Pathobiology of left ventricular dyssynchrony and resynchronization. Progress in Cardiovascular Diseases, 49(1), 26–41.PubMedCrossRef
44.
Aiba, T., Hesketh, G. G., Barth, A. S., et al. (2009). Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation, 119(9), 1220–1230.PubMedCrossRef
45.
Zabel, M., Koller, B. S., Sachs, F., & Franz, M. R. (1996). Stretch-induced voltage changes in the isolated beating heart: importance of the timing of stretch and implications for stretch-activated ion channels. Cardiovascular Research, 32(1), 120–130.PubMed
46.
Akar, F. G., Spragg, D. D., Tunin, R. S., Kass, D. A., & Tomaselli, G. F. (2004). Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circulation Research, 95(7), 717–725.PubMedCrossRef
47.
Aiba, T., Barth, A., & Tomaselli, G. F. (2008). Deciphering gene expression profiling in cardiac resynchronization therapy. Journal of the American College of Cardiology, 52(14), 1177. author reply 1177–8.PubMedCrossRef
48.
Aiba, T., & Tomaselli, G. F. (2010). Electrical remodeling in the failing heart. Current Opinion in Cardiology, 25(1), 29–36.PubMedCrossRef
49.
Chakir, K., Depry, C., Dimaano, V. L., et al. (2011). G{alpha}s-biased {beta}2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart. Science Translational Medicine, 3(100), 100ra88.PubMedCrossRef
50.
Kass, D. A. (2005). Cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology, 16(Suppl 1), S35–S41.PubMedCrossRef
51.
Vollmann, D., Lüthje, L., Schott, P., Hasenfuss, G., & Unterberg-Buchwald, C. (2006). Biventricular pacing improves the blunted force–frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation, 113(7), 953–959.PubMedCrossRef
52.
Chakir, K., Daya, S. K., Aiba, T., et al. (2009). Mechanisms of enhanced-adrenergic reserve from cardiac resynchronization therapy. Circulation, 119(9), 1231–1240.PubMedCrossRef
53.
De Sousa, E., Veksler, V., Minajeva, A., et al. (1999). Subcellular creatine kinase alterations. Implications in heart failure. Circulation Research, 85(1), 68–76.PubMed
54.
Knaapen, P., van Campen, L. M. C., de Cock, C. C., et al. (2004). Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation, 110(6), 646–651.PubMedCrossRef
55.
Agnetti, G., Kaludercic, N., Kane, L. A., et al. (2010). Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circulation. Cardiovascular Genetics, 3(1), 78–87.PubMedCrossRef
56.
Chung, E. S., Leon, A. R., Tavazzi, L., et al. (2008). Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation, 117(20), 2608–2616.PubMedCrossRef
57.
Abraham, T., Kass, D., Tonti, G., et al. (2009). Imaging cardiac resynchronization therapy. Journal of the American College of Cardiology: Cardiovascular Imaging, 2(4), 486–497.
58.
Iyengar, S., Haas, G., Lamba, S., et al. (2007). Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy. Journal of Cardiac Failure, 13(4), 304–311.PubMedCrossRef
Metadaten
Titel
Cellular Electrophysiological Abnormalities in Dyssynchronous Hearts and During CRT
verfasst von
Marc Vanderheyden
Martin Penicka
Jozef Bartunek
Publikationsdatum
01.04.2012
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 2/2012
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-011-9335-6

Weitere Artikel der Ausgabe 2/2012

Journal of Cardiovascular Translational Research 2/2012 Zur Ausgabe

OriginalPaper

Electrical and Mechanical Ventricular Activation During Left Bundle Branch Block and Resynchronization

OriginalPaper

Animal Models of Dyssynchrony

OriginalPaper

The “Missing” Link Between Acute Hemodynamic Effect and Clinical Response

OriginalPaper

Modeling Cardiac Electromechanics and Mechanoelectrical Coupling in Dyssynchronous and Failing Hearts

OriginalPaper

Right Ventricular Pacing, Mechanical Dyssynchrony, and Heart Failure

OriginalPaper

Acute and Chronic Response to CRT in Narrow QRS Patients

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise